Galantamine in Alzheimer's disease.
Galantamine is a cholinesterase inhibitor with a dual mechanism of action. It is a reversible inhibitor of acetylcholine esterase and enhances the intrinsic action of acetylcholine on nicotinic receptors, leading to increased cholinergic neurotransmission in the CNS. Galantamine has a large volume c...
Main Authors: | Razay, G, Wilcock, G |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2008
|
Similar Items
-
The beneficial effects of galantamine on caregiver time in Alzheimer's disease
by: Sano, M, et al.
Published: (2003) -
The effects of galantamine treatment on caregiver time in Alzheimer's disease.
by: Sano, M, et al.
Published: (2003) -
Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group.
by: Wilcock, G, et al.
Published: (2000) -
Hyperinsulinaemia and Alzheimer's disease.
by: Razay, G, et al.
Published: (1994) -
A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease.
by: Wilcock, G, et al.
Published: (2003)